The Danish pharmaceutical giant Novo Nordisk initiated a revolution in weight management with its groundbreaking therapies Ozempic and Wegovy. However, the company now faces a period of substantial upheaval following
All posts tagged in pharmaceutical industry
45Articles
The United Kingdom has signed a new trade agreement with South Korea, projected to contribute an additional £400 million annually to its economy. This deal replaces the 2019 post-Brexit arrangement
The UK faces a surge in counterfeit weight loss injections as criminal groups target a lucrative and vulnerable market. Recent warnings from the pharmaceutical sector highlight an exponential rise in
Dame Emma Walmsley, departing chief executive of GSK, has emphasised the critical need for further improvements within the United Kingdom’s life sciences commercial environment. Speaking following the recent UK United
The pharmaceutical sector has welcomed the announcement by the Department of Health that the NHS rebate rate for newer medicines will fall to 14.5 per cent next year, down from
The UK is facing mounting pressure from the United States to reform its drug pricing policies, with the US ambassador, Warren Stephens, delivering a stark ultimatum to government officials and
Two of the world’s largest pharmaceutical conglomerates have become embroiled in an escalating takeover battle for Metsera, an emerging biotech on the verge of breakthroughs in weight-loss drug innovation. Novo
Dame Emma Walmsley has announced her departure as chief executive of GSK, marking the end of a transformative chapter for one of Britain’s most prominent pharmaceutical firms. During her tenure
Dr Aseem Malhotra’s address at the recent Reform UK party conference in Birmingham sent ripples through the pharmaceutical sector and political circles alike. Known for his vocal opposition to Covid19
Denmark’s pharmaceutical powerhouse Novo Nordisk is set to axe 9000 jobs, marking one of the most substantial workforce reductions in its history, as the company battles a steeply declining share
Novo Nordisk, the Danish pharmaceutical titan known for its diabetes and weight loss treatments Ozempic and Wegovy, now faces a period of significant turbulence. The company has issued a stark
The UK government’s recently unveiled life sciences sector plan has faced sharp criticism from industry leaders for failing to address key concerns about investment in innovative medicines. The 78-page strategy,
The potential departure of AstraZeneca from the London Stock Exchange would deliver a ‘devastating blow’ to British markets, former Chancellor Lord Lamont warned Parliament today. The Conservative peer emphasised that
In a landmark transaction, US pharmaceutical behemoth Merck has secured the acquisition of London-based Verona Pharma for approximately $10 billion, marking a significant milestone in the biotech sector. The deal
WeightWatchers is embarking on a transformative journey following a significant debt restructuring, positioning itself to compete in the evolving landscape of weight management solutions. The company, which recently emerged from
AstraZeneca, Britain’s largest drugmaker, has faced sharp criticism over its handling of the detention of Leon Wang, its former head of international and China operations. Wang has reportedly remained in
